How Long Are You Contagious With COVID: The Timeline

Most people with COVID are contagious for roughly a week to ten days after symptoms begin, with peak infectiousness concentrated in the first five or so days. A large systematic review of viral culture studies found that the rate of positive cultures drops steeply between day five and day nine, falling from around 50% in the first few days to about 11% by day nine and near zero after that. But this average timeline hides real variation: some people clear the virus in under a week, while others shed infectious particles for two or three weeks or longer, depending on immune status, vaccination history, and how their body handles the infection.

When Peak Contagiousness Hits and How Quickly It Fades

The virus does not spread evenly across the course of illness. A systematic review pooling data from multiple viral-culture studies found that positive cultures peaked at roughly 44% to 50% of samples collected within the first five days of symptoms, then dropped to about 28% by day seven and 11% by day nine. By days ten through seventeen, culture positivity ranged between zero and 8%.¹ In another analysis of ten virus-culture studies, half found that the last day live virus could be isolated fell within ten days of symptom onset. In the other half, live virus was isolated beyond day ten in roughly 3% of patients.²

A longitudinal cohort study of 95 non-hospitalized adults tracked multiple markers simultaneously, giving a clearer picture of how each measure declines. The median time from symptom onset to a negative viral culture was eleven days, while the median to a negative PCR result exceeded nineteen days. Beyond two weeks, live virus growth was rarely detected, yet PCR still picked up viral RNA in about half of those tested between days twenty-one and thirty.³ This gap between what PCR detects and what is actually infectious matters enormously for understanding the difference between “testing positive” and “being contagious,” a distinction covered in more detail below.

Spreading Before You Know You Are Sick

One of the features that made COVID so difficult to contain from the start is that people transmit the virus before they feel ill. One analysis estimated that the median point of transmission onset was about 1.3 days after symptom onset, but the peak of transmission actually fell roughly 0.7 days before symptoms appeared. Pre-symptomatic transmission accounted for an estimated 37% of all transmission events.⁴ That means over a third of infections are passed along by people who do not yet realize they are sick.

A separate study that tracked both PCR-detectable virus and live infectious virus found that while about 63% of cases had detectable viral RNA before symptoms started, only about 20% were shedding virus that could actually infect cells in the pre-symptomatic window. Symptom onset occurred a median of three days before both peak viral RNA and peak infectious viral load.⁵ So while pre-symptomatic spread is real and significant, the most dangerous period for spreading tends to cluster around the day symptoms first appear and the few days immediately following.

What Your Rapid Test Actually Tells You About Contagiousness

A positive rapid antigen test is a reasonably good sign that you are still contagious, but a negative one is not a reliable all-clear. A CDC-supported study comparing daily antigen test results against same-day viral cultures found that rapid tests caught about 80% of culture-positive cases. However, when measured against PCR results, overall antigen test sensitivity was only about 47%.⁶ This makes sense when you understand that PCR picks up viral fragments long after you have stopped being infectious. Antigen tests are better at tracking actual infectiousness, but they still miss some people who are shedding live virus.

The cohort study of 95 adults found that one specific marker, the nucleocapsid (N) antigen, was strongly associated with the ability to grow live virus in culture. Between days six and ten after symptom onset, the presence of N antigen was linked to about an eightfold increase in the likelihood that a sample would test culture-positive. Neither PCR positivity nor the presence of ongoing symptoms reliably predicted culture positivity during that same window.³ In practical terms, if your rapid antigen test is still lighting up positive, you should treat yourself as potentially contagious. If it turns negative and you are past day five, you are probably in the clear, though the test is not perfect.

How Variants Changed the Incubation Period

The time between exposure and symptom onset has shifted with each major variant, and this matters for contagiousness because the infectious window is anchored to symptom onset. A large French case-series analysis found that the mean incubation period was about 4.6 days for the original strain, roughly 5 days for Alpha, around 4.4 days for Delta, and about 3.6 days for Omicron.⁷ A study from Singapore found even more dramatic differences, reporting median incubation periods of eleven days for the original Wuhan strain, three days for Delta, and three days for Omicron.⁸

However, the picture is not as clear-cut as these raw numbers suggest. One analysis argued that when you adjust for how rapidly each variant was spreading through the population at the time of measurement, the forward-looking incubation periods for Delta and Omicron were actually similar, both around 4.1 to 4.2 days.⁹ The short version: Omicron’s faster apparent onset may partly reflect who was getting caught in surveillance during a fast-moving wave rather than the virus itself behaving fundamentally differently. Either way, with current variants the incubation period sits somewhere around three to five days for most people, which means the contagious window typically opens a day or two before symptoms and runs through roughly a week after they start.

Why Some People Stay Contagious for Weeks

The average timeline of a week to ten days applies to most people with functioning immune systems. For those who are immunocompromised, the story can be dramatically different. A systematic review looking specifically at prolonged shedding in immunocompromised individuals found that the median duration of culture-confirmed infectious virus was about 60 days from symptom onset, with the longest documented case stretching to 238 days.¹⁰ That is months of shedding virus capable of infecting others.

A more granular study examining Omicron shedding specifically found that moderately immunocompromised patients cleared infectious virus by day ten, similar to the general population. But among severely immunocompromised patients on B-cell depletion therapy, culture-positive samples were still appearing after day twenty.¹¹ The severity of immune suppression, not just its presence, determines how long someone remains a risk to others. People on strong immunosuppressive medications for organ transplants, certain cancers, or autoimmune diseases should be aware that standard timelines may not apply to them.

A comparison study looking at how immunocompromised patients clear COVID versus influenza found strikingly different kinetics: the median time to culture-confirmed viral clearance was about 29 days for SARS-CoV-2 versus just 4.5 days for influenza in matched groups of immunocompromised patients.¹² COVID simply takes far longer for a weakened immune system to bring under control.

Viral Shedding in Children

Children shed the virus for a broadly similar duration through the respiratory tract, with a mean of about eleven days from symptom onset based on compiled data from pediatric cases. But they show a peculiar pattern with gastrointestinal shedding: the mean duration of viral shedding through stool was about 24 days from symptom onset, and in roughly 89% of cases, gastrointestinal shedding persisted even after throat or nasal swabs had turned negative, sometimes for up to four weeks.¹³ It is worth noting that this shedding was measured by PCR, not viral culture, so the presence of virus in stool does not necessarily mean a child is still spreading live virus to others through that route. Respiratory transmission remains the dominant concern. Still, the prolonged gastrointestinal shedding is something pediatricians track, and it explains why some children continue testing positive on PCR long after they seem well.

Asymptomatic Carriers and Silent Spread

Not everyone who carries and transmits the virus ever develops symptoms. A meta-analysis examining transmission from people who remained asymptomatic throughout their infection found an overall asymptomatic transmission rate of about 25% across studied clusters. The rate varied by setting: roughly 15% among familial clusters, about 29% among adult contacts, and around 24% among children’s contacts.¹⁴ Asymptomatic carriers tend to have lower viral loads on average than symptomatic individuals, which is likely why their transmission rate is lower. But a quarter of transmissions occurring from people who never feel sick is still substantial and is a key reason why symptom-based screening was never sufficient on its own.

How Vaccination Affects Transmission

Vaccination does not eliminate the ability to spread the virus, but it shortens and dampens it. A cohort study of close contacts found that vaccination of the infected person reduced their infectiousness by about 44% in social settings. Vaccination of the contact reduced their susceptibility by about 69%. When both the infected person and the contact were vaccinated, overall transmissibility dropped by roughly 74%. In household settings, where exposure is more intense and prolonged, the protective effects were somewhat smaller: vaccination of the infected person reduced infectiousness by about 13%, and vaccination of the contact reduced susceptibility by about 61%.¹⁵ The household gap makes intuitive sense: when you are living in close quarters with someone who is sick, even a reduced viral load has many chances to find its way to you.

The Problem With the Five-Day Isolation Rule

When the CDC shortened its recommended isolation period to five days in late 2021, the decision was pragmatic rather than perfectly evidence-based. The science that has come in since then paints a mixed picture. A study of healthcare workers with Omicron found that the median time from symptom onset to negative viral culture was four days, and the residual risk of transmission after five days of isolation appeared low.¹⁶

But other data told a less reassuring story. One study found that among healthcare workers returning for testing between days five and ten, 43% still had positive rapid antigen tests. The rate was highest, at 58%, among those returning on day six.¹⁷ Another study evaluating rapid antigen testing for isolation decisions found that viral cultures were still positive in about 35% of individuals tested on day six.¹⁸ In other words, somewhere between a third and half of people are still producing either a positive rapid test or detectable live virus at the five-day mark. The five-day rule works as a population-level compromise between infection control and keeping society running, but it is not a clean biological boundary. If you are trying to minimize risk to a vulnerable person in your household, testing before ending isolation is a smarter approach than counting days alone.

Virus in the Air You Breathe Out

The contagiousness timeline is ultimately about how much virus you are exhaling. A study that directly measured viral RNA in exhaled breath found that the amount of SARS-CoV-2 copies exhaled per minute remained relatively stable from days one through six after symptom onset, then dropped sharply around day eight. After day eight, exhaled viral levels fell near or below the detection threshold.¹⁹ This sharp drop aligns well with the culture-positivity data showing a steep decline between days five and nine. The exhaled-breath data is useful because it is closer to the actual mechanism of spread: what matters is not how much virus is sitting in your nose, but how much is getting launched into the air.

Interestingly, a separate study of hospitalized patients found that viral loads in exhaled breath followed a different trajectory than nasal swab samples. While nasal swabs showed declining virus over the two weeks after diagnosis, exhaled-breath samples remained more stable or even increased slightly during the same period, with higher variability in swab results compared to breath samples.²⁰ This suggests that nasal swab testing, while convenient, may not always track perfectly with the amount of virus you are actually breathing out. The hospitalized population studied there was sicker than average, so the findings may not generalize to mild outpatient infections, but the disconnect between swab results and exhaled virus is a real limitation that researchers continue to investigate.

Super-Spreading and Why Averages Mislead

One of COVID’s most distinctive features is extreme variation in how much any individual spreads the virus. Unlike influenza, where most infected people transmit at roughly similar rates, SARS-CoV-2 follows a pattern where the majority of infected people transmit to nobody at all, while a small fraction infect many others. Super-spreading events tend to happen when someone shedding at a very high viral load encounters a large number of people in conditions favorable to transmission, like crowded indoor spaces with poor ventilation.²¹

This matters for how you think about the contagiousness timeline. The average timeline says peak infectiousness is in the first few days, and that is true at a population level. But whether you personally infect anyone depends not just on when in your illness you are, but on how high your individual viral load peaks, the ventilation in the spaces you share with others, how close and prolonged your contacts are, and whether those contacts have prior immunity. Two people on day three of symptoms, sitting at the same table, can have wildly different viral loads and pose completely different risks to those around them. The timeline gives you a probability map, but individual variation can shift that map significantly in either direction.

Antiviral Treatment and Viral Rebound

Paxlovid (nirmatrelvir-ritonavir) and molnupiravir can shorten symptom duration and reduce hospitalization risk, but there has been widespread concern about “Paxlovid rebound,” where people test positive again after finishing the course. A study examining this found that viral rebound occurred in about 1.0% of nirmatrelvir-ritonavir users, 0.8% of molnupiravir users, and 0.6% of people who took no antiviral at all.²² The rebound rate was slightly higher with antivirals than without, but the absolute difference was small. The broader concern is what rebound means for contagiousness: if virus returns to detectable levels, the person could theoretically be infectious again. In practice, rebound episodes tend to be brief and involve lower viral loads than the initial peak, but they add an unpredictable wrinkle to the timeline. If you experience a return of symptoms or a newly positive rapid test after a few days of feeling better, it is reasonable to treat yourself as potentially contagious again until symptoms resolve and tests turn negative.